SRTA Overview

Strata Critical Medical, Inc. is a time-critical logistics and medical services provider to the United States healthcare industry. The Company operates air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated one call solution for donor organ recovery. Its core services include air and ground logistics, surgical organ recovery, organ placement and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands. The Company provides air and ground transportation of human organs for transplant as well as related staff, equipment, blood samples, and tissue samples. Its preservation services include operation of devices utilized to preserve organs prior to being transplanted into a recipient. Its other clinical services include cardiac care and others.

Wall Street analysts forecast SRTA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SRTA is9.63 USD with a low forecast of 8.00 USD and a high forecast of 11.25 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Strata Critical Medical Inc revenue for the last quarter amounts to 67.38M USD, increased 87.45

Strata Critical Medical Inc. EPS for the last quarter amounts to 0.02 USD, decreased -150.00

Strata Critical Medical Inc (SRTA) has 601 emplpoyees as of June 20 2026.

Today SRTA has the market capitalization of 508.78M USD.